— Know what they know.
Not Investment Advice

BMCS OTC

BioTech Medics, Inc.
1W: +0.0% 1M: +100.0% 3M: +100.0% YTD: -97.5% 1Y: -97.7% 3Y: -98.7% 5Y: -99.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 55 · $41071 mcap · Short 75% of daily vol

Balance Sheet Trends

Total Assets
$100M +0.0% ▲
Total Liabilities
$438K +1.4% ▲
5Y CAGR: +32.5%
Shareholders Equity
$100M -0.0% ▼
Cash & Investments
$0 -100.0% ▼
Total Debt
$2K -92.6% ▼
Net Debt
$2K -92.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$9-$726$0$102$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$9-$726$0$102$0
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$9-$726$0$102$0
Property, Plant & Equip.$373-$13K-$13K-$13K-$13K
Goodwill & Intangibles$0$15K$15K$15K$15K
Long-Term Investments$0$70M$70M$100M$100M
Other Non-Current Assets$0$0$0$15K$0
Total Non-Current Assets$373$70M$70M$100M$100M
Total Assets$382$70M$70M$100M$100M
— Liabilities —
Accounts Payable$0$0$0$40K$36K
Short-Term Debt$0$0$0$27K$2K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$187K$328K$426K$6K$40K
Total Current Liabilities$187K$328K$426K$432K$438K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$187K$328K$426K$432K$438K
— Equity —
Common Stock$202K$202K$202K$202K$205K
Retained Earnings-$1M-$2M-$2M-$2M-$2M
Accumulated OCI$1M$71M$71M-$202K$0
Total Stockholders Equity-$187K$70M$70M$100M$100M
Total Liabilities & Equity$382$70M$70M$100M$100M
— Key Metrics —
Total Debt$0$0$0$27K$2K
Net Debt-$9$726$0$27K$2K
Total Investments$0$70M$70M$100M$100M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms